期刊论文详细信息
BMC Microbiology
Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells
Chuan-Fa Chang1  Jen-Ren Wang1  Chun-Keung Yu2  Ya-Fang Wang1  Sheng-Wen Huang1  Hsin-Yueh Chang1  Yueh-Tung Liu3  Pei-Yi Su1 
[1] Center of Infectious Disease and Signaling Research, Medical College, National Cheng Kung University, No. 1, University Road, Tainan 70101, Taiwan;National Applied Research Laboratories, National Laboratory Animal Center, No. 128 Academia Road Section 2, Nan-Kang, Taipei 11529, Taiwan;Blood Bank, Kaohsiung Veterans General Hospital, No. 386, Ta-Chung 1st Road, Kaohsiung 81362, Taiwan
关键词: Lectin affinity chromatography;    SK-N-SH;    RD;    Sialic acid;    Enterovirus 71;   
Others  :  1221802
DOI  :  10.1186/1471-2180-12-162
 received in 2012-05-07, accepted in 2012-07-24,  发布年份 2012
PDF
【 摘 要 】

Background

Enterovirus 71 (EV71) is a major causative agent of hand-foot-and-mouth disease (HFMD), and infection of EV71 to central nerve system (CNS) may result in a high mortality in children less than 2 years old. Although there are two highly glycosylated membrane proteins, SCARB2 and PSGL-1, which have been identified as the cellular and functional receptors of EV71, the role of glycosylation in EV71 infection is still unclear.

Results

We demonstrated that the attachment of EV71 to RD and SK-N-SH cells was diminished after the removal of cell surface sialic acids by neuraminidase. Sialic acid specific lectins, Maackia amurensis (MAA) and Sambucus Nigra (SNA), could compete with EV71 and restrained the binding of EV71 significantly. Preincubation of RD cells with fetuin also reduced the binding of EV71. In addition, we found that SCARB2 was a sialylated glycoprotein and interaction between SCARB2 and EV71 was retarded after desialylation.

Conclusions

In this study, we demonstrated that cell surface sialic acids assist in the attachment of EV71 to host cells. Cell surface sialylation should be a key regulator that facilitates the binding and infection of EV71 to RD and SK-N-SH cells.

【 授权许可】

   
2012 Su et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150803205348935.pdf 563KB PDF download
Figure 9. 34KB Image download
Figure 8. 28KB Image download
Figure 7. 52KB Image download
Figure 6. 95KB Image download
Figure 5. 48KB Image download
Figure 4. 73KB Image download
Figure 3. 41KB Image download
Figure 2. 56KB Image download
Figure 1. 41KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】
  • [1]Schmidt NJ, Lennette EH, Ho HH: An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129:304-309.
  • [2]Ho M: Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000, 33:205-216.
  • [3]Lin KH, Hwang KP, Ke GM, Wang CF, Ke LY, Hsu YT, Tung YC, Chu PY, Chen BH, Chen HL, et al.: Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol 2006, 78:254-262.
  • [4]Li CC, Yang MY, Chen RF, Lin TY, Tsao KC, Ning HC, Liu HC, Lin SF, Yeh WT, Chu YT, Yang KD: Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis 2002, 34:104-109.
  • [5]Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, Su IJ: Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 2002, 40:10-15.
  • [6]Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ: An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 2000, 17:13-22.
  • [7]Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR: An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999, 341:929-935.
  • [8]Chang SC, Lin JY, Lo LY, Li ML, Shih SR: Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol 2004, 10:338-349.
  • [9]Liang CC, Sun MJ, Lei HY, Chen SH, Yu CK, Liu CC, Wang JR, Yeh TM: Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J Med Virol 2004, 74:597-603.
  • [10]Chen LC, Shyu HW, Chen SH, Lei HY, Yu CK, Yeh TM: Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol 2006, 78:780-786.
  • [11]Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, AbuBakar S, Lambert M: Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998, 133:795-798.
  • [12]Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H: Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009, 15:794-797.
  • [13]Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S: Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009, 15:798-801.
  • [14]Sears P, Wong CH: Enzyme action in glycoprotein synthesis. Cell Mol Life Sci 1998, 54:223-252.
  • [15]Varki A: Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
  • [16]Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70:5282-5287.
  • [17]Basu A, Kanda T, Beyene A, Saito K, Meyer K, Ray R: Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol 2007, 81:3933-3941.
  • [18]Lee E, Pavy M, Young N, Freeman C, Lobigs M: Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res 2006, 69:31-38.
  • [19]Escribano-Romero E, Jimenez-Clavero MA, Gomes P, Garcia-Ranea JA, Ley V: Heparan sulphate mediates swine vesicular disease virus attachment to the host cell. J Gen Virol 2004, 85:653-663.
  • [20]Witvrouw M, De Clercq E: Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol 1997, 29:497-511.
  • [21]Kuipers ME, Huisman JG, Swart PJ, de Bethune MP, Pauwels R, Schuitemaker H, De Clercq E, Meijer DK: Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:419-429.
  • [22]Rey MW, Woloshuk SL, deBoer HA, Pieper FR: Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res 1990, 18:5288.
  • [23]Powell MJ, Ogden JE: Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res 1990, 18:4013.
  • [24]Lin TY, Chu C, Chiu CH: Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J Infect Dis 2002, 186:1161-1164.
  • [25]Weng TY, Chen LC, Shyu HW, Chen SH, Wang JR, Yu CK, Lei HY, Yeh TM: Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Res 2005, 67:31-37.
  • [26]Alexander DA, Dimock K: Sialic acid functions in enterovirus 70 binding and infection. J Virol 2002, 76:11265-11272.
  • [27]Nilsson EC, Jamshidi F, Johansson SM, Oberste MS, Arnberg N: Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J Virol 2008, 82:3061-3068.
  • [28]Lehmann F, Tiralongo E, Tiralongo J: Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life Sci 2006, 63:1331-1354.
  • [29]Yang B, Chuang H, Yang KD: Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 2009, 6:141. BioMed Central Full Text
  • [30]Chang CF, Pan JF, Lin CN, Wu IL, Wong CH, Lin CH: Rapid characterization of sugar-binding specificity by in-solution proximity binding with photosensitizers. Glycobiology 2011, 21:895-902.
  • [31]Kansas GS: Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259-3287.
  • [32]Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
  • [33]Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000, 69:531-569.
  • [34]Sheu BS, Odenbreit S, Hung KH, Liu CP, Sheu SM, Yang HB, Wu JJ: Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol 2006, 101:36-44.
  • [35]Heyningen SV: Cholera toxin: interaction of subunits with ganglioside GM1. Science 1974, 183:656-657.
  • [36]Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA: Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997, 233:224-234.
  • [37]Russell RJ, Stevens DJ, Haire LF, Gamblin SJ, Skehel JJ: Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj J 2006, 23:85-92.
  • [38]Cermelli C, Cuoghi A, Scuri M, Bettua C, Neglia RG, Ardizzoni A, Blasi E, Iannitti T, Palmieri B: In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. Virol J 2011, 8:141. BioMed Central Full Text
  • [39]Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T: Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein. Antiviral Res 2010, 88:236-243.
  • [40]Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK: A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 2004, 78:7916-7924.
  • [41]Butterfield DA, Owen JB: Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorder. Proteomics Clin Appl 2011, 5:50-56.
  • [42]Wei X, Dulberger C, Li L: Characterization of murine brain membrane glycoproteins by detergent assisted lectin affinity chromatography. Anal Chem 2010, 82:6329-6333.
  • [43]Alvarez-Manilla G, Warren NL, Atwood J, Orlando R, Dalton S, Pierce M: Glycoproteomic analysis of embryonic stem cells: identification of potential glycobiomarkers using lectin affinity chromatography of glycopeptides. J Proteome Res 2010, 9:2062-2075.
  • [44]Powlesland AS, Hitchen PG, Parry S, Graham SA, Barrio MM, Elola MT, Mordoh J, Dell A, Drickamer K, Taylor ME: Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiology 2009, 19:899-909.
  • [45]Franco Fraguas L, Carlsson J, Lonnberg M: Lectin affinity chromatography as a tool to differentiate endogenous and recombinant erythropoietins. J Chromatogr A 2008, 1212:82-88.
  • [46]Yamayoshi S, Koike S: Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 2011, 85:4937-4946.
  文献评价指标  
  下载次数:76次 浏览次数:15次